SCHEMBL12098360

SCHEMBL12098360

CNc1cnc(Cl)cc1-c1ccc(F)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 2/20 0.43
KCNH2 Q12809 3/20 0.40
GRIN2B Q13224 3/20 0.40
GRIN1 Q05586 2/20 0.40
CDK9 P50750 4/20 0.40
CDK1 P06493 2/20 0.40
CDK2 P24941 2/20 0.40
CDK4 P11802 1/20 0.40
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39
SCN9A Q15858 2/20 0.39
GSK3A P49840 1/20 0.38
IRAK1 P51617 1/20 0.38
SCN5A Q14524 1/20 0.38
CASP3 P42574 2/20 0.38
CASP7 P55210 2/20 0.38
CCNT1 O60563 1/20 0.38
GSK3B P49841 1/20 0.38
CDK7 P50613 1/20 0.38
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12098181 0.85 GPBAR1 (0.44) GPBAR1KCNH2GRIN2BGRIN1CDK9
SCHEMBL15649934 0.83 CDK9 (0.48) GPBAR1KCNH2GRIN2BGRIN1CDK9
SCHEMBL30777928 0.83 CDK9 (0.48) GPBAR1KCNH2GRIN2BGRIN1CDK9
SCHEMBL1873067 0.83 ABL1 (0.39) GPBAR1KCNQ3KCNQ2GSK3AGSK3B
SCHEMBL1872308 0.82 GPBAR1 (0.46) GPBAR1GRIN2BGRIN1KCNQ3KCNQ2
SCHEMBL15301701 0.80 KCNH2 (0.42) KCNH2GRIN2BCDK9CDK1CDK2
SCHEMBL1875898 0.79 GPBAR1 (0.41) GPBAR1CDK2KCNQ3KCNQ2
SCHEMBL12097354 0.78 GPBAR1 (0.47) GPBAR1KCNH2CDK9CDK1CDK2
SCHEMBL12098356 0.77 GPBAR1 (0.43) GPBAR1KCNH2GRIN2BGRIN1CDK9
SCHEMBL1875629 0.77 ABL1 (0.41) KCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10385022-B2 3-amino-pyridines as GPBAR1 agonists HOFFMANN-LA ROCHE INC. (US) 2019-08-20 US disclosed
US-20150152058-A1 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS HOFFMANN-LA ROCHE INC. 2015-06-04 US disclosed
EP-2681194-B1 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS HOFFMANN LA ROCHE (CH) 2015-04-15 EP disclosed
US-8987307-B2 3-amino-pyridines as GPBAR1 agonists HOFFMANN-LA ROCHE INC. (US) 2015-03-24 US disclosed
EP-2681194-A1 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2014-01-08 EP disclosed
US-20120232051-A1 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS HOFFMANN-LA ROCHE INC. 2012-09-13 US disclosed
WO-2012117000-A1 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2012-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10385022-B2 3-amino-pyridines as GPBAR1 agonists GPBAR1, ADRA1B, GPR119 GPBAR1 1/4885KCNH2 614/4885GRIN2B 161/4885
US-20120232051-A1 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS GPBAR1, ADRA1B, GPR119 GPBAR1 1/4885KCNH2 614/4885GRIN2B 161/4885
US-20150152058-A1 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS GPBAR1, ADRA1B, GPR119 GPBAR1 1/4885KCNH2 614/4885GRIN2B 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.